Global Type 2 Diabetes Market- 2020-2027

Global Type 2 Diabetes Market- 2020-2027

Global Type 2 Diabetes Market is segmented By Drug Class (Oral Antidiabetics, Insulin), By Distribution Channel (Hospitals, Retail Pharmacy, Online Pharmacy), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2020-2027

Market Overview
The Global Type 2 Diabetes Market is expected to grow at a CAGR of 7.5% during the forecasting period (2020-2027).
Diabetes is a chronic condition characterized by high blood sugar, insulin resistance, and a relative lack of insulin.
Type 2 diabetes (T2D) is the most prevalent form of diabetes mellitus. Type 2 diabetes is treated with lifestyle modifications, oral medications, and insulin.
Around 90% of people with diabetes have type 2 diabetes.
WHO predicts that T2D will be the seventh leading cause of death by 2030.
Global Type 2 diabetes market is estimated to reach USD 64 billion by 2026.
Market Growth
An ever-increasing prevalence of diabetes and increased usage of anti-diabetic drugs with non-glycemic benefits will drive the market.
Also, the rich pipeline of novel agents is expected to get launched.
However, the availability of inexpensive generics will hamper market growth.
Market Segmentation
Global Type 2 diabetes market report segments the market by drug class, distribution channel and by region.
Based on part treatment type, the market is segmented into Biguanides, Sulfonylureas, Alpha-glucosidase inhibitors, Thiazolidinediones, Glucagon-like peptide-1 receptor agonists, Dipeptidyl peptidase four inhibitors, Sodium-glucose cotransporter two inhibitors, and Insulin.
Geographically, the market is segmented into five major regions, namely North America, South America, Europe, Asia Pacific, and RoW.
North America is the largest market for Type 2 diabetes owing to the high market penetration of insulin and other antidiabetic drugs.
The region was the most mature market in 2017 accounting for over 45% of the market.
Scope of the Report
The report also profiles the following companies of type 2 diabetes market – Novo Nordisk, Merck & Co. Inc., Pfizer, Astra Zeneca, Bristol-Myers Squibb, Eli Lilly, Takeda, Johnson & Johnson, Sanofi, and others.
By Drug Class
Biguanides
Sulfonylureas
Alpha-glucosidase inhibitors
Thiazolidinediones
Glucagon-like peptide-1 receptor agonists (GLP-1 agonist)
Dipeptidyl peptidase four inhibitors (DPP-4 inhibitors)
Sodium-glucose cotransporter two inhibitors (SGLT – 2)
Insulin
By Distribution Channel
Hospitals
Retail Pharmacy
Online Pharmacy
By Region
Asia Pacific (China, Japan, India, Australia, Rest of Asia Pacific)
Europe (Germany, France, The UK, Italy, Spain, Rest of Europe)
North America (The USA, Canada, Mexico)
South America (Brazil, Argentina, Rest of South America)
Rest of the World
Reasons for purchasing this report?
Visualize the composition of Type 2 diabetes market across each indication, regarding type and treatment options, highlighting the critical commercial assets and players.
Identify commercial opportunities in the Type 2 diabetes market by analyzing trends and co-development deals.
Excel data sheet with thousands of data points of the market – level 4/5 segmentation.
PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
Product mapping in excel for crucial products of all major market players
Who can benefit from this report?
Equipment Suppliers/ Buyers
Service Providers/ Buyers
Industry Investors/Investment Bankers
Education & Research Institutes
Research Professionals
Emerging Companies
Manufacturers

Related Reports:
Diabetes Therapeutics Market
Diabetes devises Market